InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Regains Compliance to Remain Listed on Nasdaq Capital Market
AnPac Bio (NASDAQ: ANPC), a biotechnology company focused on early cancer screening and detection, today announced that The Nasdaq Stock Market LLC has determined that it has regained compliance with the requirements to remain listed on The Nasdaq Capital Market, as required by a hearing panel’s decision dated May 4, 2022, subject to a one-year mandatory monitoring by the panel of the company’s ongoing compliance.…